Farmaceutica REMEDIA (RMAH) Stock Overview
Operates a chain of pharmacies in Romania. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
RMAH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Farmaceutica REMEDIA S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RON 0.86 |
| 52 Week High | RON 0.95 |
| 52 Week Low | RON 0.60 |
| Beta | 0.17 |
| 1 Month Change | -4.67% |
| 3 Month Change | 17.53% |
| 1 Year Change | 33.23% |
| 3 Year Change | 43.00% |
| 5 Year Change | -11.09% |
| Change since IPO | 284.93% |
Recent News & Updates
Recent updates
Farmaceutica REMEDIA's (BVB:RMAH) Promising Earnings May Rest On Soft Foundations
Sep 05
Farmaceutica REMEDIA's (BVB:RMAH) Dividend Will Be Reduced To RON0.04
Mar 23Farmaceutica REMEDIA's (BVB:RMAH) Soft Earnings Are Actually Better Than They Appear
Mar 06Returns At Farmaceutica REMEDIA (BVB:RMAH) Are On The Way Up
Mar 04Farmaceutica REMEDIA's (BVB:RMAH) Returns On Capital Are Heading Higher
Mar 07Returns Are Gaining Momentum At Farmaceutica REMEDIA (BVB:RMAH)
Aug 18We Like These Underlying Return On Capital Trends At Farmaceutica REMEDIA (BVB:RMAH)
Mar 23Does Farmaceutica REMEDIA (BVB:RMAH) Deserve A Spot On Your Watchlist?
Feb 16Is There More To The Story Than Farmaceutica REMEDIA's (BVB:RMAH) Earnings Growth?
Jan 15Is Farmaceutica REMEDIA S.A.'s (BVB:RMAH) Recent Performance Tethered To Its Attractive Financial Prospects?
Dec 16
Should You Invest In Farmaceutica REMEDIA (BVB:RMAH)?
Nov 18Shareholder Returns
| RMAH | RO Consumer Retailing | RO Market | |
|---|---|---|---|
| 7D | -4.9% | -5.3% | -2.2% |
| 1Y | 33.2% | 15.1% | 45.0% |
Return vs Industry: RMAH exceeded the RO Consumer Retailing industry which returned 15.1% over the past year.
Return vs Market: RMAH underperformed the RO Market which returned 45% over the past year.
Price Volatility
| RMAH volatility | |
|---|---|
| RMAH Average Weekly Movement | 4.1% |
| Consumer Retailing Industry Average Movement | 4.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in RO Market | 10.3% |
| 10% least volatile stocks in RO Market | 3.1% |
Stable Share Price: RMAH has not had significant price volatility in the past 3 months compared to the RO market.
Volatility Over Time: RMAH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 230 | Valentin-Norbert Tarus | www.corporate.remedia.ro/ |
Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics, promotion and marketing of drugs, and pharmaceutical products registration services.
Farmaceutica REMEDIA S.A. Fundamentals Summary
| RMAH fundamental statistics | |
|---|---|
| Market cap | RON 82.35m |
| Earnings (TTM) | RON 8.72m |
| Revenue (TTM) | RON 759.76m |
Is RMAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMAH income statement (TTM) | |
|---|---|
| Revenue | RON 759.76m |
| Cost of Revenue | RON 720.41m |
| Gross Profit | RON 39.35m |
| Other Expenses | RON 30.63m |
| Earnings | RON 8.72m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Mar 27, 2026
| Earnings per share (EPS) | 0.092 |
| Gross Margin | 5.18% |
| Net Profit Margin | 1.15% |
| Debt/Equity Ratio | 0% |
How did RMAH perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/09 19:44 |
| End of Day Share Price | 2026/03/09 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Farmaceutica REMEDIA S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.